IGF1 and myeloid sarcoma: The pathophysiology of growth impairment in MS may include insufficient glucose uptake for adequate tissue energy, decreased circulating insulin-like growth factor 1 (IGF-1), growth hormone resistance, and hyperadrenocorticism [3].